Sapphire Star Partners’s Cantel Medical Corporation CMD Stock Holding History

Sapphire Star Partners’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$691K	Buy	9,283 +238	+3%	+$19.6K	0.92%	38
2018 Q3	$833K	Buy	9,045 +438	+5%	+$41.7K	0.83%	42
2018 Q2	$846K	Buy	8,607 +642	+8%	+$71.8K	0.87%	39
2018 Q1	$887K	Buy	7,965 +171	+2%	+$19.2K	0.98%	30
2017 Q4	$802K	Buy	7,794 +5,262	+208%	+$524K	0.95%	33
2017 Q3	$238K	Buy	+2,532	New	+$200K	0.31%	67
2017 Q2	–	Sell	-4,123	Closed	-$330K	–	97
2017 Q1	$330K	Buy	4,123 +339	+9%	+$26.9K	0.38%	51
2016 Q4	$298K	Buy	+3,784	New	+$294K	0.33%	55

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Sapphire Star Partners's CMD Position: Q4 2018 in Review

Sapphire Star Partners increased its Cantel Medical Corporation (CMD) stake by 2.6% in Q4 2018, buying an estimated $19.6K and bringing the position to 9,283 shares worth $691K. The position accounts for 0.92% of the portfolio, ranked #38.

Sapphire Star Partners first reported a position in CMD in Q4 2016 and has held it in 8 quarters since. The position peaked at $887K in Q1 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

Sapphire Star Partners held 9,283 shares of Cantel Medical Corporation worth $691K as of Q4 2018.
Sapphire Star Partners bought 238 Cantel Medical Corporation shares in Q4 2018, an estimated $19.6K.
Cantel Medical Corporation made up 0.92% of Sapphire Star Partners's portfolio in Q4 2018, its #38 holding.
Sapphire Star Partners first reported a position in Cantel Medical Corporation in Q4 2016 and has held it in 8 quarters since.
Sapphire Star Partners's Cantel Medical Corporation position peaked at $887K in Q1 2018.
253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.